Redhill Biophrma ADR (RDHL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Sales | 1,056 | 1,590 | 1,401 | 1,563 | 1,737 |
| Cost of Goods | 1,715 | 788 | 629 | 425 | 417 |
| Gross Profit | -659 | 802 | 772 | 1,138 | 1,320 |
| Operating Expenses | 17,072 | 13,354 | 11,245 | 13,943 | 10,950 |
| Operating Income | -17,016 | -11,764 | -9,844 | -12,380 | -9,213 |
| Interest Expense | 355 | -828 | 161 | 74 | 1,031 |
| Other Income | 214 | -755 | 170 | 1,546 | 374 |
| Pre-tax Income | -17,157 | -11,691 | -9,835 | -10,908 | -9,870 |
| Net Income Continuous | -17,157 | -11,691 | -9,835 | -10,908 | -9,870 |
| Net Income | $-17,157 | $-11,691 | $-9,835 | $-10,908 | $-9,870 |
| EPS Basic Total Ops | -500.00 | -400.00 | -300.00 | -400.00 | -300.00 |
| EPS Basic Continuous Ops | -486.45 | -345.64 | -346.68 | -384.51 | -347.92 |
| EPS Diluted Total Ops | -500.00 | -400.00 | -300.00 | -400.00 | -300.00 |
| EPS Diluted Continuous Ops | -486.45 | -345.64 | -346.68 | -384.51 | -347.92 |
| EBITDA(a) | $-16,666 | $-11,511 | $-9,556 | $-12,155 | $-8,982 |